Elizabeth Howard
Plus aucun poste en cours
Fortune : - $ au 30/04/2024
Provenance du réseau au premier degré de Elizabeth Howard
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 30 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Elizabeth Howard via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal President | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director of Finance/CFO Chairman Director/Board Member Chairman | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Founder Director/Board Member Chief Executive Officer | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| University of British Columbia | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| UNILIFE CORP | Medical Specialties | Director of Finance/CFO Compliance Officer | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Chief Executive Officer President | |
| EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Chairman | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Medical Specialties | President Director/Board Member | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Pharmaceuticals: Other | Sales & Marketing Corporate Officer/Principal | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
AAIPharma, Inc.
 AAIPharma, Inc. Miscellaneous Commercial ServicesCommercial Services AAIPharma, Inc. provides product development services to the pharmaceutical, biotechnology and medical device industries. Its services include drug delivery technologies, contract manufacturing, clinical packaging and distribution and bioanalytical services. The company was founded in 1979 and is headquartered in Wilmington, NC. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| University of Kansas Medical School | College/University | Doctorate Degree | |
| Yale Law School | College/University | Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree | |
Campus Venture Network, Inc.
 Campus Venture Network, Inc. Internet Software/ServicesTechnology Services Campus Venture Network, Inc. operates a website. The private company is based in Cary, NC. The company was founded by S. Travis May, Vivek Ramaswamy. | Internet Software/Services | Founder | |
Strive Asset Management LLC
 Strive Asset Management LLC Investment ManagersFinance Part of Strive Enterprises, Inc., Strive Asset Management LLC is an asset management firm based in Dublin, OH. The company's mission is to restore the voices of everyday citizens in the American economy by leading companies to focus on excellence over politics. Strive will compete directly with the world's largest asset managers by launching index funds that advance excellence capitalism across corporate America. The company was founded by Vivek Ramaswamy and Anson Frericks in 2022, and Matthew Cole has been the CEO of the company since 2022. | Investment Managers | Founder | |
Renaissance BioScience Corp.
 Renaissance BioScience Corp. Miscellaneous Commercial ServicesCommercial Services Renaissance BioScience Corp. is a bioengineering private company based in Vancouver, Canada. The Canadian company specializes in microbial bioengineering innovation and develop market-ready, functional microorganisms for various industries such as agriculture, food and beverage, health, and energy. Renaissance BioScience's proprietary strain collections, breeding knowledge, fermentation, and screening platforms are used to engineer and deliver unique, scalable solutions for industry and academia. The company's technologies have created products that impact millions of people worldwide, including acrylamide-reducing yeast for safer foods and H2S-preventing wine yeast. More information about the Renaissance group of companies is available on their website. The company was founded by John Husnik and Maurice Boucher, and John Husnik has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Investment Managers | Analyst-Equity | |
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada | Biotechnology | Chief Tech/Sci/R&D Officer | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Oregon Health & Science University | College/University | Doctorate Degree | |
| WINDTREE THERAPEUTICS, INC. | Pharmaceuticals: Major | Public Communications Contact | |
| POLYMEDIX, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact |
Statistiques
Internationale
| Etats-Unis | 34 |
| Canada | 10 |
| Royaume-Uni | 6 |
| Suisse | 2 |
| Irlande | 2 |
Sectorielle
| Health Technology | 37 |
| Consumer Services | 8 |
| Finance | 4 |
| Commercial Services | 4 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 125 |
| Corporate Officer/Principal | 52 |
| Independent Dir/Board Member | 33 |
| Chief Executive Officer | 30 |
| Director of Finance/CFO | 28 |
Relations les plus connectées
| Insiders | |
|---|---|
| Myrtle Potter | 41 |
| Frank Torti | 35 |
| Daniel Burgess | 28 |
| Michael Jeffrey Abrams | 16 |
| Adam Daniel Cutler | 16 |
| Vivek Ramaswamy | 14 |
| Bruce G. Cousins | 14 |
| David Hastings | 12 |
| Eric Venker | 12 |
| John Naftzger | 12 |
| Frank Karbe | 11 |
| William T. Symonds | 11 |
| Andrew Cheng | 10 |
| James Meyers | 9 |
| Mark M. Kowalski | 9 |
- Bourse
- Insiders
- Elizabeth Howard
- Connexions Sociétés